BACH1 and pancreatic neoplasm: Notably, recent work demonstrates that sustained NRF2 activation can stabilise BACH1 by inducing HO-1, thereby inhibiting BACH1 degradation and enhancing the metastatic potential, particularly in lung [16] and pancreatic cancers [17].